VTGN: Vistagen Therapeutics Inc Financial Statements
Balance sheet, income statement, and cash flow statements for Vistagen Therapeutics Inc (VTGN).
$72.16M Market Cap.
VTGN Market Cap. (MRY)
VTGN Shares Outstanding (MRY)
VTGN Assets (MRY)
Total Assets
$84.34M
Total Liabilities
$13.95M
Total Investments
$13.35M
VTGN Income (MRY)
Revenue
$486.00K
Net Income
-$51.42M
Operating Expense
$56.46M
VTGN Cash Flow (MRY)
CF Operations
-$42.10M
CF Investing
-$13.15M
CF Financing
$3.21M
VTGN Balance Sheet (MRY)
Metric | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
Total Assets | $84,341,000 (-31.79%) | $123,653,000 (486.34%) | $21,089,000 (-71.75%) | $74,643,400 (-31.07%) |
Assets Current | $82,076,000 (-31.98%) | $120,672,000 (589.28%) | $17,507,000 (-75.34%) | $70,998,000 (-31.81%) |
Assets Non-Current | $2,265,000 (-24.02%) | $2,981,000 (-16.78%) | $3,582,000 (-1.74%) | $3,645,400 (-12.45%) |
Goodwill & Intangible Assets | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Shareholders Equity | $70,390,000 (-38.41%) | $114,286,000 (846.08%) | $12,080,000 (-81.33%) | $64,715,300 (-29.64%) |
Property Plant & Equipment Net | $1,811,000 (-19.69%) | $2,255,000 (-18.50%) | $2,767,000 (-10.05%) | $3,076,300 (-14.24%) |
Cash & Equivalents | $67,131,000 (-43.67%) | $119,166,000 (616.23%) | $16,638,000 (-75.58%) | $68,135,300 (-33.92%) |
Accumulated Other Comprehensive Income | $5,000 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Deferred Revenue | $2,979,000 (-14.03%) | $3,465,000 (14.39%) | $3,029,000 (8.12%) | $2,801,600 (-28.36%) |
Total Investments | $13,351,000 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Investments Current | $13,351,000 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Investments Non-Current | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Inventory | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Trade & Non-Trade Receivables | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Trade & Non-Trade Payables | $653,000 (-57.79%) | $1,547,000 (-37.44%) | $2,473,000 (-10.35%) | $2,758,600 (229.07%) |
Accumulated Retained Earnings (Deficit) | -$407,632,000 (-14.43%) | -$356,214,000 (-8.98%) | -$326,852,000 (-22.14%) | -$267,604,000 (-21.73%) |
Tax Assets | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Tax Liabilities | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Total Debt | $1,509,000 (-28.82%) | $2,120,000 (-21.80%) | $2,711,000 (-10.78%) | $3,038,700 (-18.28%) |
Debt Current | $561,000 (2.00%) | $550,000 (-6.94%) | $591,000 (36.40%) | $433,300 (17.81%) |
Debt Non-Current | $948,000 (-39.62%) | $1,570,000 (-25.94%) | $2,120,000 (-18.63%) | $2,605,400 (-22.25%) |
Total Liabilities | $13,951,000 (48.94%) | $9,367,000 (3.97%) | $9,009,000 (-9.26%) | $9,928,100 (-39.10%) |
Liabilities Current | $12,612,000 (146.18%) | $5,123,000 (12.00%) | $4,574,000 (-20.66%) | $5,765,100 (37.62%) |
Liabilities Non-Current | $1,339,000 (-68.45%) | $4,244,000 (-4.31%) | $4,435,000 (6.53%) | $4,163,000 (-65.63%) |
VTGN Income Statement (MRY)
Metric | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
Revenues | $486,000 (-54.32%) | $1,064,000 (568.72%) | -$227,000 (-120.47%) | $1,108,900 (1.78%) |
Cost of Revenue | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Selling General & Administrative Expense | $17,084,000 (21.48%) | $14,063,000 (-4.10%) | $14,664,000 (8.78%) | $13,480,000 (89.92%) |
Research & Development Expense | $39,375,000 (96.66%) | $20,022,000 (-54.88%) | $44,377,000 (25.33%) | $35,407,800 (196.90%) |
Operating Expenses | $56,459,000 (65.64%) | $34,085,000 (-42.27%) | $59,041,000 (20.77%) | $48,887,800 (156.99%) |
Interest Expense | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Income Tax Expense | $7,000 (75.00%) | $4,000 (-33.33%) | $6,000 (76.47%) | $3,400 (30.77%) |
Net Loss Income from Discontinued Operations | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Consolidated Income | -$51,418,000 (-75.12%) | -$29,362,000 (50.44%) | -$59,248,000 (-24.05%) | -$47,762,400 (-166.32%) |
Net Income to Non-Controlling Interests | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Income | -$51,418,000 (-75.12%) | -$29,362,000 (50.44%) | -$59,248,000 (-24.05%) | -$47,762,400 (-166.32%) |
Preferred Dividends Income Statement Impact | $0 (0%) | $0 (0%) | $0 (0%) | $945,100 (-96.12%) |
Net Income Common Stock | -$51,418,000 (-75.12%) | -$29,362,000 (50.44%) | -$59,248,000 (-21.64%) | -$48,707,500 (-15.09%) |
Weighted Average Shares | $30,877,029 (59.53%) | $19,354,500 (178.13%) | $6,958,749 (5.45%) | $6,599,287 (129.85%) |
Weighted Average Shares Diluted | $30,877,029 (59.53%) | $19,354,500 (178.13%) | $6,958,749 (5.45%) | $6,599,287 (129.85%) |
Earning Before Interest & Taxes (EBIT) | -$51,411,000 (-75.12%) | -$29,358,000 (50.44%) | -$59,242,000 (-24.04%) | -$47,759,000 (-166.34%) |
Gross Profit | $486,000 (-54.32%) | $1,064,000 (568.72%) | -$227,000 (-120.47%) | $1,108,900 (1.78%) |
Operating Income | -$55,973,000 (-69.51%) | -$33,021,000 (44.29%) | -$59,268,000 (-24.05%) | -$47,778,900 (-166.42%) |
VTGN Cash Flow Statement (MRY)
Metric | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
Net Cash Flow from Investing | -$13,148,000 (-21454.10%) | -$61,000 (91.76%) | -$740,000 (-269.26%) | -$200,400 (27.23%) |
Net Cash Flow from Financing | $3,210,000 (-97.50%) | $128,402,000 (12434.49%) | -$1,041,000 (-109.93%) | $10,483,900 (-90.81%) |
Net Cash Flow from Operations | -$42,097,000 (-63.08%) | -$25,813,000 (48.08%) | -$49,716,000 (-9.85%) | -$45,256,500 (-274.84%) |
Net Cash Flow / Change in Cash & Cash Equivalents | -$52,035,000 (-150.75%) | $102,528,000 (299.10%) | -$51,497,000 (-47.25%) | -$34,973,000 (-134.37%) |
Net Cash Flow - Business Acquisitions and Disposals | $0 (0%) | $0 (0%) | -$528,000 (0%) | $0 (0%) |
Net Cash Flow - Investment Acquisitions and Disposals | -$12,957,000 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Capital Expenditure | -$191,000 (-213.11%) | -$61,000 (71.23%) | -$212,000 (-5.79%) | -$200,400 (27.23%) |
Issuance (Repayment) of Debt Securities | $0 (0%) | -$985,000 (4.74%) | -$1,034,000 (-34366.67%) | -$3,000 (99.21%) |
Issuance (Purchase) of Equity Shares | $3,210,000 (-97.52%) | $129,387,000 (1848485.71%) | -$7,000 (-100.07%) | $10,486,900 (-90.84%) |
Payment of Dividends & Other Cash Distributions | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Effect of Exchange Rate Changes on Cash | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Share Based Compensation | $4,315,000 (97.75%) | $2,182,000 (-34.59%) | $3,336,000 (-4.16%) | $3,480,700 (50.93%) |
Depreciation Amortization & Accretion | $635,000 (11.80%) | $568,000 (6.77%) | $532,000 (-25.19%) | $711,100 (48.89%) |
VTGN Financial Metrics (MRY)
Metric | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
Gross Margin | 100.00% (0.00%) | 100.00% (0.00%) | 100.00% (0.00%) | 100.00% (0.00%) |
Profit Margin | -10579.80% (-283.38%) | -2759.60% (-110.57%) | 26100.40% (694.22%) | -4392.40% (-13.08%) |
EBITDA Margin | -10447.70% (-286.12%) | -2705.80% (-110.46%) | 25863.40% (709.58%) | -4242.80% (-164.84%) |
Return on Average Equity (ROAE) | -58.90% (-40.57%) | -41.90% (80.83%) | -218.60% (-248.64%) | -62.70% (31.70%) |
Return on Average Assets (ROAA) | -52.40% (-39.36%) | -37.60% (76.17%) | -157.80% (-199.43%) | -52.70% (24.06%) |
Return on Sales (ROS) | -10578.40% (-283.39%) | -2759.20% (-110.57%) | 26097.80% (705.95%) | -4306.90% (-161.67%) |
Return on Invested Capital (ROIC) | -592.70% (35.47%) | -918.50% (57.95%) | -2184.40% (-52.51%) | -1432.30% (-357.60%) |
Dividend Yield | 0% (0%) | 0% (0%) | 0% (0%) | 0% (0%) |
Price to Earnings Ratio (P/E) | -1.5 (56.91%) | -3.47 (-689.55%) | -0.44 (91.27%) | -5.04 (-15.97%) |
Price to Sales Ratio (P/S) | 158.83 (65.37%) | 96.05 (183.75%) | -114.68 (-151.80%) | 221.39 (31.47%) |
Price to Book Ratio (P/B) | 1.02 (-17.93%) | 1.25 (-44.83%) | 2.26 (-42.78%) | 3.96 (20.60%) |
Debt to Equity Ratio (D/E) | 0.2 (141.46%) | 0.08 (-89.01%) | 0.75 (387.58%) | 0.15 (-13.56%) |
Earnings Per Share (EPS) | -1.67 (-9.87%) | -1.52 (82.14%) | -8.51 (-15.31%) | -7.38 (49.80%) |
Sales Per Share (SPS) | 0.02 (-70.91%) | 0.06 (266.67%) | -0.03 (-119.64%) | 0.17 (-55.67%) |
Free Cash Flow Per Share (FCFPS) | -1.37 (-2.47%) | -1.34 (81.37%) | -7.17 (-4.17%) | -6.89 (-60.15%) |
Book Value Per Share (BVPS) | 2.28 (-61.39%) | 5.91 (240.15%) | 1.74 (-82.30%) | 9.81 (-69.39%) |
Tangible Assets Book Value Per Share (TABVPS) | 2.73 (-57.24%) | 6.39 (110.79%) | 3.03 (-73.20%) | 11.31 (-70.01%) |
Enterprise Value Over EBIT (EV/EBIT) | 0 (0%) | -1 (0%) | 0 (0%) | -4 (63.64%) |
Enterprise Value Over EBITDA (EV/EBITDA) | 0.02 (102.66%) | -0.64 (-587.10%) | -0.09 (97.51%) | -3.73 (67.66%) |
Asset Turnover | 0.01 (-64.29%) | 0.01 (333.33%) | -0.01 (-150.00%) | 0.01 (-33.33%) |
Current Ratio | 6.51 (-72.37%) | 23.55 (515.33%) | 3.83 (-68.92%) | 12.31 (-50.45%) |
Dividends | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Free Cash Flow (FCF) | -$42,288,000 (-63.44%) | -$25,874,000 (48.18%) | -$49,928,000 (-9.84%) | -$45,456,900 (-268.10%) |
Enterprise Value (EV) | -$846,788 (-104.60%) | $18,388,604 (236.88%) | $5,458,518 (-96.89%) | $175,536,064 (-12.83%) |
Earnings Before Tax (EBT) | -$51,411,000 (-75.12%) | -$29,358,000 (50.44%) | -$59,242,000 (-24.04%) | -$47,759,000 (-166.34%) |
Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) | -$50,776,000 (-76.37%) | -$28,790,000 (50.96%) | -$58,710,000 (-24.79%) | -$47,047,900 (-169.55%) |
Invested Capital | $6,107,000 (311.52%) | $1,484,000 (-42.66%) | $2,588,000 (-31.57%) | $3,781,700 (-19.58%) |
Working Capital | $69,464,000 (-39.88%) | $115,549,000 (793.44%) | $12,933,000 (-80.17%) | $65,232,900 (-34.72%) |
Tangible Asset Value | $84,341,000 (-31.79%) | $123,653,000 (486.34%) | $21,089,000 (-71.75%) | $74,643,400 (-31.07%) |
Market Capitalization | $72,155,212 (-49.43%) | $142,693,104 (421.73%) | $27,350,018 (-89.32%) | $256,094,664 (-15.15%) |
Average Equity | $87,322,250 (24.72%) | $70,016,250 (158.34%) | $27,102,875 (-65.14%) | $77,742,400 (68.64%) |
Average Assets | $98,173,000 (25.88%) | $77,987,275 (107.65%) | $37,556,275 (-59.35%) | $92,396,600 (51.48%) |
Invested Capital Average | $8,674,000 (171.38%) | $3,196,300 (17.85%) | $2,712,075 (-18.66%) | $3,334,400 (-41.81%) |
Shares | 28,862,085 (6.80%) | 27,025,209 (269.66%) | 7,310,811 (6.20%) | 6,884,196 (45.76%) |
